GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » EV-to-FCF

Minapharm Pharmaceuticals (CAI:MIPH) EV-to-FCF : (As of Dec. 12, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Minapharm Pharmaceuticals's Enterprise Value is E£4,754 Mil. Minapharm Pharmaceuticals does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Minapharm Pharmaceuticals's EV-to-FCF at this moment.

The historical rank and industry rank for Minapharm Pharmaceuticals's EV-to-FCF or its related term are showing as below:

CAI:MIPH' s EV-to-FCF Range Over the Past 10 Years
Min: -3.6   Med: 0   Max: 0
Current: -3.6

CAI:MIPH's EV-to-FCF is ranked worse than
100% of 552 companies
in the Drug Manufacturers industry
Industry Median: 25.86 vs CAI:MIPH: -3.60

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-12), Minapharm Pharmaceuticals's stock price is E£202.01. Minapharm Pharmaceuticals does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023. Therefore, GuruFocus does not calculate Minapharm Pharmaceuticals's PE Ratio (TTM) at this moment.


Minapharm Pharmaceuticals EV-to-FCF Historical Data

The historical data trend for Minapharm Pharmaceuticals's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals EV-to-FCF Chart

Minapharm Pharmaceuticals Annual Data
Trend Dec22 Dec23
EV-to-FCF
-4.37 -3.55

Minapharm Pharmaceuticals Semi-Annual Data
Dec22 Dec23
EV-to-FCF - -

Competitive Comparison of Minapharm Pharmaceuticals's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Minapharm Pharmaceuticals's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Minapharm Pharmaceuticals's EV-to-FCF falls into.



Minapharm Pharmaceuticals EV-to-FCF Calculation

Minapharm Pharmaceuticals's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4754.230/
=


Minapharm Pharmaceuticals  (CAI:MIPH) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Minapharm Pharmaceuticals's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=202.01/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Minapharm Pharmaceuticals EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Minapharm Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY
Minapharm Pharmaceuticals is a company whose purpose is to produce medicines and chemicals. medical supplies. cosmetics, veterinary medicines, dental supplies, and the production of dietary supplements and herbal medicines. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals Headlines

No Headlines